Annexon, Inc.
INHIBITORS OF COMPLEMENT FACTORS AND USES THEREOF
Last updated:
Abstract:
Disclosed are compounds of formula I and II and pharmaceutically acceptable salts thereof. Also disclosed are methods of treating a neurodegenerative disorder, an inflammatory disease, an autoimmune disease, an ophthalmic disease or a metabolic disorder using the compounds disclosed herein.
Status:
Application
Type:
Utility
Filling date:
19 Jul 2021
Issue date:
17 Feb 2022